Verve Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.0M | 1.6M | 4.84 |
| 2024-06-30 | $8.3M | 1.7M | 4.88 |
| 2024-03-31 | $20M | 1.5M | 13.28 |
| 2023-12-31 | $29M | 2.1M | 13.94 |
| 2023-09-30 | $33M | 2.5M | 13.26 |
| 2023-06-30 | $34M | 1.8M | 18.67 |
| 2023-03-31 | $28M | 1.9M | 14.43 |
| 2022-12-31 | $35M | 1.8M | 19.35 |
| 2022-06-30 | $21M | 1.4M | 15.28 |
| 2022-03-31 | $26M | 1.1M | 22.82 |
| 2021-12-31 | $32M | 877k | 36.86 |